SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-24-004802
Filing Date
2024-04-08
Accepted
2024-04-08 08:31:40
Documents
14
Period of Report
2024-04-03
Items
Item 1.02: Termination of a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 8-K cydy-20240403x8k.htm   iXBRL 8-K 34370
  Complete submission text file 0001558370-24-004802.txt   163984

Data Files

Seq Description Document Type Size
2 EX-101.SCH cydy-20240403.xsd EX-101.SCH 3405
3 EX-101.LAB cydy-20240403_lab.xml EX-101.LAB 16919
4 EX-101.PRE cydy-20240403_pre.xml EX-101.PRE 11938
17 EXTRACTED XBRL INSTANCE DOCUMENT cydy-20240403x8k_htm.xml XML 4261
Mailing Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660
Business Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660 360-980-8524
CytoDyn Inc. (Filer) CIK: 0001175680 (see all company filings)

IRS No.: 753056237 | State of Incorp.: DE | Fiscal Year End: 0531
Type: 8-K | Act: 34 | File No.: 000-49908 | Film No.: 24828240
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)